• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剖宫产术后直肠米索前列醇对肠动力的影响。

The effect of post-cesarean rectal misoprostol on intestinal motility.

机构信息

Department of Obstetrics, Gynecology and Perinatology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.

出版信息

Int J Gynaecol Obstet. 2012 Nov;119(2):159-62. doi: 10.1016/j.ijgo.2012.05.033. Epub 2012 Aug 25.

DOI:10.1016/j.ijgo.2012.05.033
PMID:22925817
Abstract

OBJECTIVE

To determine whether rectally administered misoprostol can induce intestinal motility compared with oxytocin infusion when used to prevent primary postpartum hemorrhage after cesarean delivery.

METHODS

In a prospective randomized double-blind study in Nigeria, 218 parturients undergoing cesarean delivery who had risk factors for primary postpartum hemorrhage were enrolled between July 1, 2010, and March 31, 2011. Participants received 600 μg of rectal misoprostol or 20 intravenous units of oxytocin for 4 hours after surgery. The primary outcome was time until passage of flatus. Adverse effects, need for additional analgesic, and length of hospital stay were also assessed.

RESULTS

The misoprostol group had a significantly shorter mean postoperative interval to passage of flatus (20.27 ± 7.77 hours versus 38.34 ± 10.98 hours; P<0.001) and commencement of regular diet (21.08 ± 7.69 hours versus 39.13 ± 10.94 hours; P<0.001). Gastrointestinal adverse effects were more frequent, albeit not significantly, in the misoprostol group: nausea, 6.4% versus 1.8%; vomiting, 7.3% versus 2.8%; and abdominal distension, 3.7% versus 2.8%. The need for additional analgesic was the same in the 2 groups.

CONCLUSION

After cesarean delivery, rectal misoprostol had the added benefit of inducing intestinal motility. Misoprostol might be considered in a clinical setting where postoperative ileus is anticipated.

摘要

目的

比较剖宫产术后使用直肠米索前列醇与催产素预防原发性产后出血时对肠动力的影响。

方法

本前瞻性随机双盲研究于 2010 年 7 月 1 日至 2011 年 3 月 31 日在尼日利亚进行,纳入 218 例有原发性产后出血风险的剖宫产产妇。术后 4 小时内,产妇分别给予 600μg直肠米索前列醇或 20 个单位静脉催产素。主要结局是肛门排气时间。还评估了不良反应、需要额外镇痛药物以及住院时间。

结果

米索前列醇组术后肛门排气时间(20.27±7.77 小时比 38.34±10.98 小时;P<0.001)和开始常规饮食时间(21.08±7.69 小时比 39.13±10.94 小时;P<0.001)明显缩短。米索前列醇组胃肠道不良反应虽不显著但更常见:恶心 6.4%比 1.8%;呕吐 7.3%比 2.8%;腹胀 3.7%比 2.8%。两组需要额外镇痛药物的情况相同。

结论

与催产素相比,剖宫产术后直肠给予米索前列醇可促进肠动力。在预计术后发生肠麻痹的情况下,米索前列醇可在临床中考虑使用。

相似文献

1
The effect of post-cesarean rectal misoprostol on intestinal motility.剖宫产术后直肠米索前列醇对肠动力的影响。
Int J Gynaecol Obstet. 2012 Nov;119(2):159-62. doi: 10.1016/j.ijgo.2012.05.033. Epub 2012 Aug 25.
2
Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.经直肠给予米索前列醇与剖宫产术中静脉滴注催产素相比,以减少术中及术后失血。
Int J Gynaecol Obstet. 2010 Apr;109(1):25-9. doi: 10.1016/j.ijgo.2009.11.009. Epub 2010 Jan 13.
3
Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.直肠给药米索前列醇作为剖宫产术后预防产后出血的静脉输注缩宫素的替代方法。
J Obstet Gynaecol Res. 2014 Sep;40(9):2023-30. doi: 10.1111/jog.12464.
4
Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.剖宫产术中舌下含服米索前列醇与静脉滴注缩宫素减少失血的比较。
Int J Gynaecol Obstet. 2006 Feb;92(2):106-10. doi: 10.1016/j.ijgo.2005.10.008. Epub 2005 Dec 15.
5
Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.尼日利亚剖宫产术中舌下含服米索前列醇与静脉注射缩宫素对减少失血的效果:一项随机对照试验
J Obstet Gynaecol Res. 2011 Jul;37(7):715-21. doi: 10.1111/j.1447-0756.2010.01399.x. Epub 2011 Mar 6.
6
Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.剖宫产术中,舌下含服米索前列醇作为催产素的辅助用药,用于有产后出血风险的女性。
Int J Gynaecol Obstet. 2015 Jan;128(1):48-52. doi: 10.1016/j.ijgo.2014.07.029. Epub 2014 Sep 16.
7
Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial.剖宫产术中及术后舌下含服米索前列醇与静脉滴注缩宫素减少出血的随机临床试验
Taiwan J Obstet Gynecol. 2016 Dec;55(6):791-795. doi: 10.1016/j.tjog.2016.02.019.
8
Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.舌下含服米索前列醇与肌肉注射缩宫素预防低危产妇产后出血的比较。
Int J Gynaecol Obstet. 2012 Feb;116(2):138-42. doi: 10.1016/j.ijgo.2011.09.016. Epub 2011 Nov 17.
9
Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.直肠给予米索前列醇与静脉注射缩宫素预防产后出血的比较
Int J Gynaecol Obstet. 2009 Jun;105(3):244-7. doi: 10.1016/j.ijgo.2009.01.018. Epub 2009 Feb 26.
10
Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.米索前列醇阴道给药与缩宫素浓缩液及前列腺素E2阴道给药用于孕中期引产的比较
Obstet Gynecol. 2004 Jul;104(1):138-45. doi: 10.1097/01.AOG.0000128947.31887.94.

引用本文的文献

1
Side-effects of oxytocin in postpartum hemorrhage: a systematic review and meta-analysis.缩宫素在产后出血中的副作用:一项系统评价与荟萃分析
Am J Transl Res. 2022 Mar 15;14(3):1934-1951. eCollection 2022.
2
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.预防产后出血的宫缩剂:一项网状荟萃分析
Cochrane Database Syst Rev. 2018 Dec 19;12(12):CD011689. doi: 10.1002/14651858.CD011689.pub3.
3
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.预防产后出血的宫缩剂:一项网状Meta分析
Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2.
4
Postpartum misoprostol for preventing maternal mortality and morbidity.产后使用米索前列醇预防孕产妇死亡和发病。
Cochrane Database Syst Rev. 2013 Jul 15;2013(7):CD008982. doi: 10.1002/14651858.CD008982.pub2.
5
Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysis.米索前列醇减少剖宫产术中及术后出血:系统评价与荟萃分析。
Am J Obstet Gynecol. 2013 Jul;209(1):40.e1-40.e17. doi: 10.1016/j.ajog.2013.03.015. Epub 2013 Mar 15.